Ambev vs Anheuser-Busch InBev
ABEV and BUD side by side, both in beverages. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ABEV and BUD compare
Anheuser-Busch InBev grew revenue faster over the last twelve months (−0.75% versus −1.4% for Ambev).
Ambev keeps more of each dollar of sales as profit, with a net margin of 17.6% compared with 11.5% at Anheuser-Busch InBev.
Ambev scores higher on the StockData Score (12 against 5 for Anheuser-Busch InBev), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ABEV | BUD |
|---|---|---|
| Size and price | ||
| Share price | $2.66 | $80.38 |
| Change, 1 year | 22.0% | 30.8% |
| Change, 5 years | −17.4% | 32.2% |
| Beta (5Y) | 0.40 | 0.52 |
| Employees | 40K | 137K |
| StockData Score | ||
| Total score | 12 (better) | 5 |
| Valuation score | 0 | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 6 (better) | 4 |
| Health score | 4 (better) | 0 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −1.4% | −0.75% (better) |
| Revenue growth, 5Y average | 8.6% (better) | 4.8% |
| Net income growth (TTM) | 7.4% | 16.8% (better) |
| EPS growth (TTM) | 8.3% | 18.5% (better) |
| EPS growth, 5Y average | 6.6% | 37.5% (better) |
| Profitability | ||
| Gross margin | 51.4% | 55.9% (better) |
| Operating margin | 26.4% (better) | 26.0% |
| Net margin | 17.6% (better) | 11.5% |
| FCF margin | 22.5% (better) | 18.9% |
| Return on equity | 16.6% (better) | 7.9% |
| Return on invested capital | 25.2% (better) | 14.5% |
| Financial health | ||
| Debt / equity | 0.04 | – |
| Net debt / EBITDA | −0.65 | – |
| Interest coverage | 5.3× (better) | 3.0× |
| Current ratio | 0.96 (better) | 0.66 |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Payout ratio | – | 66.4% |
| Ownership | ||
| Held by institutions | 8.9% | 5.3% |
| Held by insiders | 0.22% | – |
| Insider net buying, 12 months | −$2.4M | – |
| Superinvestors holding | – | 1 |
Go deeper
- ABEV stock overview
- ABEV income statement
- ABEV valuation and score
- BUD stock overview
- BUD income statement
- BUD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.